Skip to main content
. 2016 Feb 2;7(21):30241–30249. doi: 10.18632/oncotarget.7148

Figure 2. Intratumoral KIT mutational heterogeneity of 4 patients.

Figure 2

FFPE sections of 19 patients identified to carry hot spots mutations of KIT by NGS were macrodissected into four regions followed by PCR amplification and Sanger sequencing. Four of 19 patients demonstrated intratumoral KIT mutational heterogeneity with concurrent wild-type and mutant tumor cells.